603882 金域医学
已收盘 07-24 15:00:00
资讯
新帖
简况
每周股票复盘：金域医学（603882）推2026年股权激励计划
证券之星 · 07-26 02:17
每周股票复盘：金域医学（603882）推2026年股权激励计划
金域医学（603882）披露2026年限制性股票与股票期权激励计划草案，7月24日股价下跌2.07%
证券之星 · 07-24 22:28
金域医学（603882）披露2026年限制性股票与股票期权激励计划草案，7月24日股价下跌2.07%
广东167家公司发布半年业绩预告，近半数净利润高速增长
第一财经 · 07-22
广东167家公司发布半年业绩预告，近半数净利润高速增长
每周股票复盘：金域医学（603882）预盈1.7亿至2.2亿元
证券之星 · 07-19
每周股票复盘：金域医学（603882）预盈1.7亿至2.2亿元
金域医学新注册《金域医学项目对照管理系统V1.1.3》项目的软件著作权
证券之星 · 07-18
金域医学新注册《金域医学项目对照管理系统V1.1.3》项目的软件著作权
金域医学上半年净利预增300%至359%；国际医学上半年预计亏损6300万元至6600万元 | 医药早参
每日经济新闻 · 07-14
金域医学上半年净利预增300%至359%；国际医学上半年预计亏损6300万元至6600万元 | 医药早参
金域医学（603882）披露2026年半年度业绩预盈公告，7月13日股价上涨4.87%
证券之星 · 07-13
金域医学（603882）披露2026年半年度业绩预盈公告，7月13日股价上涨4.87%
异动快报：金域医学（603882）7月10日11点14分触及涨停板
证券之星 · 07-10
异动快报：金域医学（603882）7月10日11点14分触及涨停板
金域医学新注册《金域产品管理项目推荐系统V1.0》等2个项目的软件著作权
证券之星 · 07-10
金域医学新注册《金域产品管理项目推荐系统V1.0》等2个项目的软件著作权
每周股票复盘：金域医学（603882）回购股份进展公布
证券之星 · 07-05
每周股票复盘：金域医学（603882）回购股份进展公布
金域医学（603882）披露回购股份进展公告，7月1日股价上涨5.2%
证券之星 · 07-01
金域医学（603882）披露回购股份进展公告，7月1日股价上涨5.2%
股市必读：金域医学（603882）6月26日收盘跌6.73%，主力净流出1081.29万元
证券之星 · 06-29
股市必读：金域医学（603882）6月26日收盘跌6.73%，主力净流出1081.29万元
每周股票复盘：金域医学（603882）2025年净亏损1.73亿
证券之星 · 06-28
每周股票复盘：金域医学（603882）2025年净亏损1.73亿
金域医学（603882）披露控股子公司认购私募基金份额公告，6月25日股价下跌0.96%
证券之星 · 06-25
金域医学（603882）披露控股子公司认购私募基金份额公告，6月25日股价下跌0.96%
金域医学（603882）披露2025年年度股东会会议资料，6月22日股价上涨0.12%
证券之星 · 06-22
金域医学（603882）披露2025年年度股东会会议资料，6月22日股价上涨0.12%
金域医学（603882）披露与关联人共同投资暨关联交易进展公告，6月18日股价上涨0.37%
证券之星 · 06-18
金域医学（603882）披露与关联人共同投资暨关联交易进展公告，6月18日股价上涨0.37%
金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务
智通财经 · 06-12
金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务
每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元
证券之星 · 06-07
每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元
金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权
证券之星 · 06-06
金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权
金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%
证券之星 · 06-02
金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%
加载更多
公司概况
公司名称：
广州金域医学检验集团股份有限公司
所属行业：
卫生
上市日期：
2017-09-08
主营业务：
广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司参与获批国家科技重大专项4项，国家“战略性科技创新合作”重点专项1项。全年发表论文共101篇，其中SCI论文32篇，学术影响力持续提升。
发行价格：
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":25.97,"timestamp":1784876401000,"preClose":26.52,"halted":0,"volume":5417901,"delay":0,"changeRate":-0.0207,"floatShares":459999999,"shares":463000000,"eps":-0.2217,"marketStatus":"已收盘","change":-0.55,"latestTime":"07-24 15:00:00","open":26.38,"high":27,"low":25.91,"amount":143000000,"amplitude":0.0411,"askPrice":25.98,"askSize":5,"bidPrice":25.97,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-0.2217,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785115800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.52,"symbolType":"stock","openAndCloseTimeList":[[1784856600000,1784863800000],[1784869200000,1784876400000]],"highLimit":29.17,"lowLimit":23.87,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":1.9,"roa":"--","roe":"0.65%","epsLYR":-0.37,"committee":-0.296296,"marketValue":12031000000,"turnoverRate":0.0118,"status":1,"floatMarketCap":11950000000},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2654057374","title":"每周股票复盘：金域医学（603882）推2026年股权激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654057374?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:17","pubTimestamp":1785003430,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，金域医学报收于25.97元，较上周的26.37元下跌1.52%。本周，金域医学7月22日盘中最高价报27.48元。公司公告汇总：金域医学将召开2026年第二次临时股东会，审议2026年股权激励计划相关议案。公司公告汇总广州金域医学检验集团股份有限公司董事会薪酬与考核委员会对2026年限制性股票与股票期权激励计划首次授予激励对象名单的公示情况进行核查。薪酬委员会认为激励对象主体资格合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","SG9999001069.SGD","603882","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653088038","title":"金域医学（603882）披露2026年限制性股票与股票期权激励计划草案，7月24日股价下跌2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653088038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653088038?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:28","pubTimestamp":1784903302,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，金域医学报收于25.97元，较前一交易日下跌2.07%，最新总市值为120.31亿元。该股当日开盘26.38元，最高27.0元，最低25.91元，成交额达1.43亿元，换手率为1.18%。近日，广州金域医学检验集团股份有限公司披露《公司2026年限制性股票与股票期权激励计划（草案）》及其摘要、《2026年限制性股票与股票期权激励计划实施考核管理办法》及提请股东会授权董事会办理本次激励计划相关事宜的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","BK0284","SG9999001069.SGD","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653026763","title":"广东167家公司发布半年业绩预告，近半数净利润高速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2653026763","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653026763?lang=zh_cn&edition=full","pubTime":"2026-07-22 21:24","pubTimestamp":1784726663,"startTime":"0","endTime":"0","summary":"7月22日，第一财经从广东证监局了解到，截至目前，广东辖区已有167家上市公司披露了2026年上半年业绩预告，占辖区上市公司总数的36%。其中，近半数公司业绩高速增长，超三成公司持续盈利且净利润同比增速超50%，20家公司扭亏为盈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817622990.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817622990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2289578879.USD","300438","BK0042","600685","BK0279","LU1997245094.SGD","BK0188","002918","BK0185","688183","LU0348766576.USD","LU1580142542.USD","BK0242","BK0007","LU1719994722.HKD","SG9999002950.SGD","BK0005","BK0024","001389","002841","002842","000100","002187","SG9999003461.SGD","LU0543330566.HKD","BK0077","BK0170","688548","BK0126","BK0093","002709","BK0235","BK0229","600428","000776","600183","BK0224","300014","EVS.SI","LU2929501877.USD","LU0708995153.HKD","IE0005HP3H50.USD","BK0182","603268","LU2495084118.USD","002192","603882","301377","BK0209","BK0155"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652728237","title":"每周股票复盘：金域医学（603882）预盈1.7亿至2.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652728237","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652728237?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:56","pubTimestamp":1784397372,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，金域医学报收于26.37元，较上周的24.62元上涨7.11%。本周，金域医学7月15日盘中最高价报29.29元。本周关注点来自业绩披露要点：金域医学预计2026年上半年归母净利润为1.7亿元至2.2亿元，同比扭亏为盈。来自公司公告汇总：公司拟实施2026年限制性股票与股票期权激励计划，授予权益总数700万股，占总股本1.51%。扣非后净利润预计盈利1.8亿元至2.3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","603882","BK0042","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652282071","title":"金域医学新注册《金域医学项目对照管理系统V1.1.3》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2652282071","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652282071?lang=zh_cn&edition=full","pubTime":"2026-07-18 02:08","pubTimestamp":1784311691,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了《金域医学项目对照管理系统V1.1.3》项目的软件著作权。今年以来金域医学新注册软件著作权36个，较去年同期减少了38.98%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了59家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息222条，著作权信息197条；此外企业还拥有行政许可62个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071800000205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0284","159180","BK0236","BK0042","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651614794","title":"金域医学上半年净利预增300%至359%；国际医学上半年预计亏损6300万元至6600万元 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2651614794","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651614794?lang=zh_cn&edition=full","pubTime":"2026-07-14 07:00","pubTimestamp":1783983650,"startTime":"0","endTime":"0","summary":"丨2026年7月14日星期二丨NO.1国际医学上半年预计亏损6300万元至6600万元7月13日，国际医学发布2026年半年度业绩预告公告，公司预计2026年半年度实现归属于母公司所有者的净利润为-6600万元至-6300万元，与上年同期的亏损1.89亿元相比，亏损有所缩窄。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607143804338663.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607143804338663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","BK0146","000516","BK0284","SG9999001069.SGD","BK0042","BK0046","BK1574","159938","BK1515","BK0236","603882","BK0096","BK0114","BK0077","BK0188","BK1161","BK0181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651611075","title":"金域医学（603882）披露2026年半年度业绩预盈公告，7月13日股价上涨4.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651611075","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651611075?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:54","pubTimestamp":1783954454,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，金域医学报收于25.82元，较前一交易日上涨4.87%，最新总市值为119.61亿元。该股当日开盘24.43元，最高26.14元，最低24.16元，成交额达4.42亿元，换手率为3.76%。近日，广州金域医学检验集团股份有限公司发布2026年半年度业绩预盈公告。本次业绩未经审计机构审计，具体财务数据以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300040976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","SG9999001069.SGD","BK0284","603882","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650906719","title":"异动快报：金域医学（603882）7月10日11点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2650906719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650906719?lang=zh_cn&edition=full","pubTime":"2026-07-10 11:15","pubTimestamp":1783653319,"startTime":"0","endTime":"0","summary":"证券之星7月10日盘中消息，11点14分金域医学（603882）触及涨停板。其所属行业医疗服务目前上涨。领涨股为和元生物。该股为CAR-T疗法，AI医疗，阿尔茨海默病概念热股，当日CAR-T疗法概念上涨4.88%，AI医疗概念上涨4.53%，阿尔茨海默病概念上涨3.99%。7月9日的资金流向数据方面，主力资金净流出367.4万元，占总成交额4.32%，游资资金净流入634.34万元，占总成交额7.46%，散户资金净流出266.94万元，占总成交额3.14%。近5日资金流向一览见下表：金域医学主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000014964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0236","BK0284","BK0042","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650979640","title":"金域医学新注册《金域产品管理项目推荐系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2650979640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650979640?lang=zh_cn&edition=full","pubTime":"2026-07-10 02:21","pubTimestamp":1783621272,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了2个项目的软件著作权，包括《金域产品管理项目推荐系统V1.0》、《物流运输数据实时监控平台V1.9.88》等。今年以来金域医学新注册软件著作权35个，较去年同期减少了40.68%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了59家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息222条，著作权信息195条；此外企业还拥有行政许可62个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","SG9999001069.SGD","BK0284","BK0236","BK0042","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649947236","title":"每周股票复盘：金域医学（603882）回购股份进展公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2649947236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649947236?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:53","pubTimestamp":1783191186,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，金域医学报收于23.86元，较上周的22.16元上涨7.67%。本周，金域医学7月2日盘中最高价报24.13元。本周关注点公司公告汇总：金域医学已累计回购661.38万股，支付金额17,342.37万元。北京市中伦律师事务所出具法律意见书，认为会议召集、召开程序、出席人员资格及表决程序合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","BK0236","BK0042","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648527544","title":"金域医学（603882）披露回购股份进展公告，7月1日股价上涨5.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527544","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648527544?lang=zh_cn&edition=full","pubTime":"2026-07-01 23:03","pubTimestamp":1782918196,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，金域医学报收于23.65元，较前一交易日上涨5.2%，最新总市值为109.56亿元。该股当日开盘22.86元，最高24.0元，最低22.31元，成交额达1.56亿元，换手率为1.46%。近日，广州金域医学检验集团股份有限公司发布《关于以集中竞价交易方式回购公司股份的进展公告》。截至2026年6月30日，已累计回购661.38万股，占总股本1.43%，支付金额17,342.37万元，回购价格区间为23.36元/股至28.79元/股。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0236","603882","BK0284","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343960","title":"股市必读：金域医学（603882）6月26日收盘跌6.73%，主力净流出1081.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647343960?lang=zh_cn&edition=full","pubTime":"2026-06-29 03:11","pubTimestamp":1782673869,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，金域医学报收于22.16元，下跌6.73%，换手率1.68%，成交量7.72万手，成交额1.75亿元。交易信息汇总股价提醒6月26日金域医学收盘报22.16元，跌6.73%，当日成交1.75亿元。前10个交易日主力资金累计净流出3271.61万元，股价累计下跌6.73%；融资余额累计减少110.09万元，融券余量累计减少4700股。资金流向6月26日主力资金净流出1081.29万元，游资资金净流入717.26万元，散户资金净流入364.03万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","BK0284","SG9999001069.SGD","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646132913","title":"每周股票复盘：金域医学（603882）2025年净亏损1.73亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2646132913","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646132913?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:41","pubTimestamp":1782585669,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，金域医学报收于22.16元，较上周的24.59元下跌9.88%。本周，金域医学6月23日盘中最高价报25.12元。公司公告汇总广州金域医学检验集团股份有限公司2025年年度股东会会议资料涵盖会议议程、董事会工作报告、利润分配预案、续聘审计机构、董事及高管薪酬管理制度、董事薪酬确认议案等内容。股本股东变化股东圣域钫持有广州金域医学检验集团股份有限公司股份21,000,000股，占总股本的4.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","SG9999001069.SGD","BK0284","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646099128","title":"金域医学（603882）披露控股子公司认购私募基金份额公告，6月25日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646099128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646099128?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:29","pubTimestamp":1782397754,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，金域医学报收于23.76元，较前一交易日下跌0.96%，最新总市值为110.07亿元。该股当日开盘23.88元，最高24.15元，最低22.88元，成交额达1.43亿元，换手率为1.33%。近日，广州金域医学检验集团股份有限公司发布《关于控股子公司认购私募基金份额的公告》。KINGWIK作为有限合伙人出资后预计占基金出资比例约4.70%。本次交易不构成关联交易，亦不构成重大资产重组，无需提交公司董事会或股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0236","BK0284","BK0042","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645107308","title":"金域医学（603882）披露2025年年度股东会会议资料，6月22日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645107308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645107308?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:47","pubTimestamp":1782139637,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，金域医学报收于24.62元，较前一交易日上涨0.12%，最新总市值为114.05亿元。该股当日开盘24.75元，最高24.75元，最低23.56元，成交额达1.26亿元，换手率为1.14%。近日，广州金域医学检验集团股份有限公司披露《2025年年度股东会会议资料》。2025年公司实现营业收入60.30亿元，同比减少16.12%，归母净利润为-1.73亿元，同比减亏54.56%。董事会共召开6次会议，审议多项重大事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","SG9999001069.SGD","BK0284","603882"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084216","title":"金域医学（603882）披露与关联人共同投资暨关联交易进展公告，6月18日股价上涨0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084216","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644084216?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:47","pubTimestamp":1781794035,"startTime":"0","endTime":"0","summary":"近日，广州金域医学检验集团股份有限公司发布《关于与关联人共同投资暨关联交易的进展公告》。公告显示，公司于2026年6月12日召开第四届董事会第十二次会议，审议通过与关联人共同投资设立广州金坤医智科技有限公司的议案；公司使用自有资金认缴出资1,000万元，持股20%。公司名称为广州金坤医智科技有限公司，法定代表人为谢江涛，成立日期为2026年6月17日，经营范围为软件和信息技术服务业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0236","BK0042","603882","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642295697","title":"金域医学(603882.SH)拟投设金坤医智 拓展医疗数智化综合解决方案业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2642295697","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642295697?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:15","pubTimestamp":1781270135,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金域医学(603882.SH)发布公告，公司拟使用自有资金与广州市圣域钫投资咨询合伙企业(有限合伙)等公司共同投资设立广州金坤医智科技有限公司(简称“金坤医智”，暂定名)，注册资本5000万元。其中，公司认缴出资1000万元，持股比例为20%。金坤医智核心业务将聚焦“智慧医疗”，基于对医疗全场景的深度洞察，整合自研AI产品与生态伙伴资源，为医院、药企、保险、IVD厂商等多元客户提供医疗数智化综合解决方案及端到端全流程数智化服务，金坤医智的业务定位与公司主营业务形成互补协同、差异发展，有助于拓展公司在智慧医疗领域的战略布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603882","BK0042","159891","BK0284","SG9999001069.SGD","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127107","title":"每周股票复盘：金域医学（603882）已回购1.01%股份支付1.26亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127107?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:46","pubTimestamp":1780771574,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，金域医学报收于24.02元，较上周的25.6元下跌6.17%。本周，金域医学6月1日盘中最高价报26.32元。本周关注点公司公告汇总：金域医学已累计回购465.87万股，占总股本1.01%，支付金额12,553.21万元。回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","603882","BK0042","BK0284","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641314238","title":"金域医学新注册《智慧检测线性区间分析系统V1.5.7》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2641314238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641314238?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:25","pubTimestamp":1780683915,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学（603882）新注册了《智慧检测线性区间分析系统V1.5.7》项目的软件著作权。今年以来金域医学新注册软件著作权33个，较去年同期减少了37.74%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.41亿元，同比减14.78%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目28次；财产线索方面有商标信息766条，专利信息221条，著作权信息194条；此外企业还拥有行政许可61个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060600000116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0236","BK0042","SG9999001069.SGD","159180","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914576","title":"金域医学（603882）披露以集中竞价交易方式回购公司股份进展公告，6月2日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914576","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914576?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:05","pubTimestamp":1780394721,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，金域医学报收于25.74元，较前一交易日下跌1.27%，最新总市值为119.24亿元。该股当日开盘26.05元，最高26.25元，最低25.53元，成交额达1.2亿元，换手率为1.01%。广州金域医学检验集团股份有限公司于2026年6月2日发布《关于以集中竞价交易方式回购公司股份的进展公告》。回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","603882","BK0042","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785087000478,"stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":0.0825},{"period":"3month","weight":-0.0817},{"period":"6month","weight":-0.2037},{"period":"1year","weight":-0.1243},{"period":"ytd","weight":-0.0585}],"compareEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":-0.0722},{"period":"3month","weight":-0.0651},{"period":"6month","weight":-0.0778},{"period":"1year","weight":0.0578},{"period":"ytd","weight":-0.039}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"43126人(较上一季度增加7.68%)","perCapita":"10669股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司参与获批国家科技重大专项4项，国家“战略性科技创新合作”重点专项1项。全年发表论文共101篇，其中SCI论文32篇，学术影响力持续提升。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}